The Only TENS Device with Sleep Technology

09/15/2020 • Shai Gozani M.D., Ph.D.

Tags: ,

There is a two-way relationship between sleep and pain.  Poor sleep makes pain worse and pain disrupts sleep.  So it is not surprising that most people with chronic pain also have poor sleep.  This may include a short sleep duration, difficulty falling asleep, waking up at night and altered sleep cycles.  Quell® offers patented technology to help control your pain while you sleep.

  • Thin device that is comfortable to wear during sleep
  • 4 sleep modes to choose from
  • Built in sleep tracker (Learn more)
  • Advanced battery technology so you only need to recharge every 3-4 days
  • Only TENS device cleared by the FDA for use during sleep*

Sleep Modes

Quell offers various sleep modes for overnight use. Sleep modes control how therapy will operate while you sleep.

Gentle OvernightOvernight therapy at reduced intensity. This is the default mode.
Bedtime OnlyTherapy only while falling asleep.
Full PowerOvernight therapy at regular daytime intensity.
As NeededTherapy only when Quell detects that you are having restless sleep.

 

 

 

 

*FDA 510(K) clearance means that the FDA has deemed the device to be as safe and effective as a medical device previously cleared by the FDA; this is called “substantially equivalent.” This process is different from FDA approval of drugs and typically does not involve a review and analysis of clinical data. All transcutaneous electrical nerve stimulators (TENS) must be FDA cleared before they are marketed. The FDA 510(k) clearance for Quell specifically states that it may be used during sleep.


About The Author
Shai Gozani M.D., Ph.D.
Shai Gozani M.D., Ph.D.

Dr. Gozani is an expert in non-invasive neurostimulation. He received his M.D. degree from Harvard Medical School and the Harvard-MIT Division of Health Science and Technology. Dr. Gozani earned his Ph.D. in Neurobiology, M.S. in Electrical Engineering & Computer Science and B.A. in Computer Science from the University of California at Berkeley. Following his studies, Dr. Gozani conducted post-doctoral research at Harvard Medical School and MIT. He holds 36 U.S. patents and has authored over 30 articles in scientific and clinical peer-reviewed journals. Dr. Gozani is founder, president and CEO of NeuroMetrix, Inc.; which designs and manufactures Quell.


Subscribe to the Living Quell Blog

Sign up for the Living Quell Blog and get the best content delivered to your inbox weekly.